Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Greenberg

Showing results (91-100 of 148) with videos related to

Pageof 15
Sort By:
BMJ (Clinical Research Ed.)|April 22, 2004
Delays in publication of cost utility analyses conducted alongside clinical trials: registry analysisDan Greenberg, Allison B Rosen, Natalia V Olchanski, et al.
Journal of Vascular and Interventional Radiology : JVIR|October 7, 2004
In-hospital costs of self-expanding nitinol stent implantation versus balloon angioplasty in the femoropopliteal artery (the VascuCoil Trial)Dan Greenberg, Kenneth Rosenfield, Lawrence A Garcia, et al.
Heart (British Cardiac Society)|April 12, 2019
Direct oral anticoagulation and mortality in moderate to high-risk atrial fibrillationRonen Arbel, Ruslan Sergienko, Ariel Hammerman, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|December 23, 2008
Nutritional risk and health care use before and after an acute hospitalization among the elderlyIlana Feldblum, Larissa German, Natalya Bilenko, et al.
BMJ (Clinical Research Ed.)|February 24, 2006
Bias in published cost effectiveness studies: systematic reviewChaim M Bell, David R Urbach, Joel G Ray, et al.
Journal of Clinical Medicine|March 17, 2025
Gender Differences in Coping Strategies and Life Satisfaction Following Cognitive-Behavioral and Mindfulness-Based Intervention for Crohn's Disease: A Randomized Controlled TrialGanit Goren, Doron Schwartz, Michael Friger, et al.
The Lancet. Infectious Diseases|May 28, 2005
A synthesis of cost-utility analysis literature in infectious diseasePatricia W Stone, Bruce R Schackman, Christopher P Neukermans, et al.
The American Journal of Managed Care|January 13, 2006
Do drug formulary policies reflect evidence of value?Peter J Neumann, Pei-Jung Lin, Dan Greenberg, et al.
Pharmacoeconomics|March 27, 2013
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statementDon Husereau, Michael Drummond, Stavros Petrou, et al.
Cost Effectiveness and Resource Allocation : C/E|March 28, 2013
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statementDon Husereau, Michael Drummond, Stavros Petrou, et al.
Pageof 15

Showing results (91-100 of 148) with videos related to

Sort By:
Pageof 15
BMJ (Clinical Research Ed.)|April 22, 2004
Delays in publication of cost utility analyses conducted alongside clinical trials: registry analysisDan Greenberg, Allison B Rosen, Natalia V Olchanski, et al.
Journal of Vascular and Interventional Radiology : JVIR|October 7, 2004
In-hospital costs of self-expanding nitinol stent implantation versus balloon angioplasty in the femoropopliteal artery (the VascuCoil Trial)Dan Greenberg, Kenneth Rosenfield, Lawrence A Garcia, et al.
Heart (British Cardiac Society)|April 12, 2019
Direct oral anticoagulation and mortality in moderate to high-risk atrial fibrillationRonen Arbel, Ruslan Sergienko, Ariel Hammerman, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|December 23, 2008
Nutritional risk and health care use before and after an acute hospitalization among the elderlyIlana Feldblum, Larissa German, Natalya Bilenko, et al.
BMJ (Clinical Research Ed.)|February 24, 2006
Bias in published cost effectiveness studies: systematic reviewChaim M Bell, David R Urbach, Joel G Ray, et al.
Journal of Clinical Medicine|March 17, 2025
Gender Differences in Coping Strategies and Life Satisfaction Following Cognitive-Behavioral and Mindfulness-Based Intervention for Crohn's Disease: A Randomized Controlled TrialGanit Goren, Doron Schwartz, Michael Friger, et al.
The Lancet. Infectious Diseases|May 28, 2005
A synthesis of cost-utility analysis literature in infectious diseasePatricia W Stone, Bruce R Schackman, Christopher P Neukermans, et al.
The American Journal of Managed Care|January 13, 2006
Do drug formulary policies reflect evidence of value?Peter J Neumann, Pei-Jung Lin, Dan Greenberg, et al.
Pharmacoeconomics|March 27, 2013
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statementDon Husereau, Michael Drummond, Stavros Petrou, et al.
Cost Effectiveness and Resource Allocation : C/E|March 28, 2013
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statementDon Husereau, Michael Drummond, Stavros Petrou, et al.
Pageof 15